1. Home
  2. LSPD vs KLRA Comparison

LSPD vs KLRA Comparison

Compare LSPD & KLRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lightspeed Commerce Inc. Subordinate Voting Shares

LSPD

Lightspeed Commerce Inc. Subordinate Voting Shares

HOLD

Current Price

$9.79

Market Cap

1.3B

Sector

N/A

ML Signal

HOLD

Logo Kailera Therapeutics Inc. Common Stock

KLRA

Kailera Therapeutics Inc. Common Stock

N/A

Current Price

$10.88

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LSPD
KLRA
Founded
2005
N/A
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
LSPD
KLRA
Price
$9.79
$10.88
Analyst Decision
Buy
Analyst Count
9
0
Target Price
★ $13.33
N/A
AVG Volume (30 Days)
549.6K
★ 976.4K
Earning Date
05-21-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$15.43
N/A
Revenue Next Year
$10.94
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.83
$10.83
52 Week High
$13.72
$23.82

Technical Indicators

Market Signals
Indicator
LSPD
KLRA
Relative Strength Index (RSI) 43.00 27.45
Support Level $9.34 N/A
Resistance Level $9.83 $19.15
Average True Range (ATR) 0.24 0.86
MACD 0.00 -0.16
Stochastic Oscillator 30.05 1.53

Price Performance

Historical Comparison
LSPD
KLRA

About LSPD Lightspeed Commerce Inc. Subordinate Voting Shares

Lightspeed Commerce Inc is a one-stop commerce platform providing its customers with the critical functionalities needed to engage with consumers, manage their operations, order their inventory, accept payments, and run their business. It has customers globally in over 100 countries, empowering single- and multi-location small and medium-sized businesses to compete in an omni-channel market environment by engaging with consumers across online, mobile, social, and physical channels. Its products are divided into retail, restaurant, and golf categories. Geographically, it operates in Canada, the United States, the United Kingdom, Switzerland, Germany, and Others with the majority of revenue deriving from Canada.

About KLRA Kailera Therapeutics Inc. Common Stock

Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity. The company is progressing four clinical-stage product candidates, leveraging multiple GLP-1 based mechanisms of action and routes of administration. The company's obesity-first approach seeks to advance product candidates with the potential to maximize weight loss and address critical needs in the current therapeutic landscape.

Share on Social Networks: